Arbutus Biopharma Corp — Investor Relations & Filings
Filings indexed
1,010
across all filing types
Latest filing
2026-04-15
Regulatory Filings
Country
US
United States of America
Listing
US
ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company focused on developing therapeutics for viral diseases, with a primary emphasis on creating a functional cure for chronic Hepatitis B virus (cHBV) infection. The company's strategy involves developing combination regimens that utilize multiple agents with complementary mechanisms of action. This approach aims to suppress viral replication, reduce viral antigens, and reawaken the host's immune response. A key candidate in its pipeline is imdusiran, an RNA interference (RNAi) therapeutic. Arbutus leverages its expertise in virology and drug delivery systems to advance its portfolio of clinical assets for patients with unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-04-15 | English | |
| DEF 14A - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-04-14 | English | |
| 8-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-03-23 | English | |
| 10-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-03-23 | English | |
| 8-K - ARBUTUS BIOPHARMA CORP (0001447028) (Filer) | 2026-03-03 | English | |
| 8-K - ARBUTUS BIOPHARMA CORP (0001447028) (Filer) | 2026-02-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 34575463 | 8-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-04-15 | English | ||
| 34525946 | DEF 14A - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-04-14 | English | ||
| 33012915 | 8-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-03-23 | English | ||
| 33012924 | 10-K - Arbutus Biopharma Corp (0001447028) (Filer) | 2026-03-23 | English | ||
| 32892038 | 8-K - ARBUTUS BIOPHARMA CORP (0001447028) (Filer) | 2026-03-03 | English | ||
| 32892039 | 8-K - ARBUTUS BIOPHARMA CORP (0001447028) (Filer) | 2026-02-20 | English | ||
| 29859389 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29859393 | 8-K Filing | 2026-02-06 | English | ||
| 29859387 | 4 Filing | 2026-02-02 | English | ||
| 29859386 | 4 Filing | 2026-02-02 | English | ||
| 29859381 | 8-K Filing | 2026-01-16 | English | ||
|
2025
4 filings
| |||||
| 12253803 | FORM 8-K | 2025-12-11 | English | ||
| 12253802 | FORM 8-K | 2025-11-13 | English | ||
| 12253804 | 10-Q | 2025-11-13 | English | ||
| 12253805 | FORM 8-K | 2025-10-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Arbutus Biopharma Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32357/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32357 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32357 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32357 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32357}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Arbutus Biopharma Corp (id: 32357)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.